Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 304

1.

Bone marrow mesenchymal stem cells in rheumatoid arthritis, spondyloarthritis, and ankylosing spondylitis: problems rather than solutions?

Berthelot JM, Le Goff B, Maugars Y.

Arthritis Res Ther. 2019 Nov 13;21(1):239. doi: 10.1186/s13075-019-2014-8. Review.

2.

Cartilage-gut-microbiome axis: a new paradigm for novel therapeutic opportunities in osteoarthritis.

Berthelot JM, Sellam J, Maugars Y, Berenbaum F.

RMD Open. 2019 Sep 20;5(2):e001037. doi: 10.1136/rmdopen-2019-001037. eCollection 2019. Review.

3.

[Placebo effect in osteoarthritis].

Berthelot JM.

Rev Prat. 2019 May;69(5):520-521. Review. French. No abstract available.

PMID:
31626456
4.

Are painDETECT scores in musculoskeletal disorders associated with duration of daily pain and time elapsed since current pain onset?

Berthelot JM, Biha N, Darrieutort-Laffite C, Le Goff B, Maugars Y.

Pain Rep. 2019 Apr 9;4(3):e739. doi: 10.1097/PR9.0000000000000739. eCollection 2019 May-Jun.

5.

Inadequate reporting of concomitant medications in rheumatology randomized controlled trials of pharmacologic interventions.

Iudici M, Riveros C, Gabay C, Puéchal X, Berthelot JM, Ravaud P.

Semin Arthritis Rheum. 2019 Dec;49(3):453-458. doi: 10.1016/j.semarthrit.2019.03.009. Epub 2019 Mar 16.

PMID:
30975475
6.

Translocation of dead or alive bacteria from mucosa to joints and epiphyseal bone-marrow: facts and hypotheses.

Berthelot JM, Wendling D.

Joint Bone Spine. 2020 Jan;87(1):31-36. doi: 10.1016/j.jbspin.2019.01.004. Epub 2019 Jan 21.

PMID:
30677505
7.

Pain catastrophising worsens RAPID3 in all rheumatologic conditions.

Berthelot JM, Bart G, Darrieutort-Lafitte C, Le Goff B, Guillot P, Glémarec J, Maugars Y.

Clin Exp Rheumatol. 2019 Jul-Aug;37(4):600-607. Epub 2019 Jan 4.

PMID:
30620285
8.

Trained Immunity and Autoimmune Disease: Did Eve Sin before Adam?

Berthelot JM, Sibilia J.

Joint Bone Spine. 2019 May;86(3):293-295. doi: 10.1016/j.jbspin.2018.12.006. Epub 2018 Dec 22. No abstract available.

PMID:
30584920
9.

The negative Hawthorne effect: Explaining pain overexpression.

Berthelot JM, Nizard J, Maugars Y.

Joint Bone Spine. 2019 Jul;86(4):445-449. doi: 10.1016/j.jbspin.2018.10.003. Epub 2018 Oct 11.

PMID:
30316973
10.

Frequency of tumour necrosis factor alpha receptor superfamily 1A multiple sclerosis-associated variants in patients with rheumatoid arthritis with anti-tumour necrosis factor therapy-related demyelinating complications.

Bitoun S, Miceli-Richard C, Verstuyft C, Juge PA, Dieudé P, Berthelot JM, Richez C, Cauquil C, Sordet C, Melac-Ducamp S, Gossec L, Bouvard B, Dernis E, Houvenagel E, Boutry-Bacle MA, Mariette X, Seror R.

Ann Rheum Dis. 2018 Dec;77(12):1835-1836. doi: 10.1136/annrheumdis-2018-213183. Epub 2018 Jul 20. No abstract available.

PMID:
30030263
11.

Opioids can paradoxically induce severe pain.

Berthelot JM, Nizard J, Maugars Y.

Joint Bone Spine. 2018 Dec;85(6):655-657. doi: 10.1016/j.jbspin.2018.04.007. Epub 2018 May 2. No abstract available.

PMID:
29729433
12.

Assessing polymyalgia rheumatica activity when C-reactive protein is unavailable or uninterpretable.

Devauchelle-Pensec V, Saraux L, Berthelot JM, De Bandt M, Cornec D, Guellec D, Marhadour T, Jousse-Joulin S, Gouillou M, Saraux A.

Rheumatology (Oxford). 2018 Apr 1;57(4):666-670. doi: 10.1093/rheumatology/kex477.

PMID:
29346621
13.

An e-health interactive self-assessment website (Sanoia®) in rheumatoid arthritis. A 12-month randomized controlled trial in 320 patients.

Gossec L, Cantagrel A, Soubrier M, Berthelot JM, Joubert JM, Combe B, Czarlewski W, Wendling D, Dernis E, Grange L, Beauvais C, Perdriger A, Nataf H, Dougados M, Servy H.

Joint Bone Spine. 2018 Dec;85(6):709-714. doi: 10.1016/j.jbspin.2017.11.015. Epub 2017 Dec 12.

14.

Impaired intracellular pathogen clearance and inflammatory joint disease: Is Whipple's disease a guiding light?

Berthelot JM, Puéchal X.

Joint Bone Spine. 2018 Oct;85(5):531-536. doi: 10.1016/j.jbspin.2017.09.007. Epub 2017 Sep 28. Review.

PMID:
28965939
15.

Long-term efficacy and safety of rituximab in IgG4-related disease: Data from a French nationwide study of thirty-three patients.

Ebbo M, Grados A, Samson M, Groh M, Loundou A, Rigolet A, Terrier B, Guillaud C, Carra-Dallière C, Renou F, Pozdzik A, Labauge P, Palat S, Berthelot JM, Pennaforte JL, Wynckel A, Lebas C, Le Gouellec N, Quémeneur T, Dahan K, Carbonnel F, Leroux G, Perlat A, Mathian A, Cacoub P, Hachulla E, Costedoat-Chalumeau N, Harlé JR, Schleinitz N.

PLoS One. 2017 Sep 15;12(9):e0183844. doi: 10.1371/journal.pone.0183844. eCollection 2017.

16.

SAPHO, autophagy, IL-1, FoxO1, and Propionibacterium (Cutibacterium) acnes.

Berthelot JM, Corvec S, Hayem G.

Joint Bone Spine. 2018 Mar;85(2):171-176. doi: 10.1016/j.jbspin.2017.04.010. Epub 2017 May 9. Review.

PMID:
28499891
17.

Stretching of roots contributes to the pathophysiology of radiculopathies.

Berthelot JM, Laredo JD, Darrieutort-Laffite C, Maugars Y.

Joint Bone Spine. 2018 Jan;85(1):41-45. doi: 10.1016/j.jbspin.2017.01.004. Epub 2017 Jan 20. Review.

PMID:
28115269
18.

Nutcracker syndrome: A rare cause of left flank pain that can also manifest as unexplained pelvic pain.

Berthelot JM, Douane F, Maugars Y, Frampas E.

Joint Bone Spine. 2017 Oct;84(5):557-562. doi: 10.1016/j.jbspin.2016.10.006. Epub 2016 Dec 5. Review.

PMID:
27932281
19.

Rheumatology: Craft, industry, or both?

Berthelot JM, Guillot P, Le Goff B, Maugars Y.

Joint Bone Spine. 2017 Jan;84(1):5-7. doi: 10.1016/j.jbspin.2016.09.008. Epub 2016 Nov 4. Review. No abstract available.

PMID:
27825578
20.

Cystic angiomatosis, a heterogeneous condition: Four new cases and a literature review.

Najm A, Soltner-Neel E, Le Goff B, Guillot P, Maugars Y, Berthelot JM.

Medicine (Baltimore). 2016 Oct;95(43):e5213. Review.

21.

High-Grade Salivary-Gland Involvement, Assessed by Histology or Ultrasonography, Is Associated with a Poor Response to a Single Rituximab Course in Primary Sjögren's Syndrome: Data from the TEARS Randomized Trial.

Cornec D, Jousse-Joulin S, Costa S, Marhadour T, Marcorelles P, Berthelot JM, Hachulla E, Hatron PY, Goeb V, Vittecoq O, Nowak E, Pers JO, Devauchelle-Pensec V, Saraux A.

PLoS One. 2016 Sep 23;11(9):e0162787. doi: 10.1371/journal.pone.0162787. eCollection 2016.

22.

Non-TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug: A Randomized Clinical Trial.

Gottenberg JE, Brocq O, Perdriger A, Lassoued S, Berthelot JM, Wendling D, Euller-Ziegler L, Soubrier M, Richez C, Fautrel B, Constantin AL, Mariette X, Morel J, Gilson M, Cormier G, Salmon JH, Rist S, Lioté F, Marotte H, Bonnet C, Marcelli C, Sellam J, Meyer O, Solau-Gervais E, Guis S, Ziza JM, Zarnitsky C, Chary-Valckenaere I, Vittecoq O, Saraux A, Pers YM, Gayraud M, Bolla G, Claudepierre P, Ardizzone M, Dernis E, Breban MA, Fain O, Balblanc JC, Aberkane O, Vazel M, Back C, Candon S, Chatenoud L, Perrodeau E, Sibilia J, Ravaud P.

JAMA. 2016 Sep 20;316(11):1172-1180. doi: 10.1001/jama.2016.13512.

PMID:
27654603
23.

Validation of FLARE-RA, a Self-Administered Tool to Detect Recent or Current Rheumatoid Arthritis Flare.

Fautrel B, Morel J, Berthelot JM, Constantin A, De Bandt M, Gaudin P, Maillefert JF, Meyer O, Pham T, Saraux A, Solau-Gervais E, Vittecoq O, Wendling D, Erpelding ML, Guillemin F; STPR Group of the French Society of Rheumatology.

Arthritis Rheumatol. 2017 Feb;69(2):309-319. doi: 10.1002/art.39850.

24.

NETosis: At the crossroads of rheumatoid arthritis, lupus, and vasculitis.

Berthelot JM, Le Goff B, Neel A, Maugars Y, Hamidou M.

Joint Bone Spine. 2017 May;84(3):255-262. doi: 10.1016/j.jbspin.2016.05.013. Epub 2016 Jul 15. Review.

PMID:
27426444
25.

Severe Health-Related Quality of Life Impairment in Active Primary Sjögren's Syndrome and Patient-Reported Outcomes: Data From a Large Therapeutic Trial.

Cornec D, Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Yves Hatron P, Goeb V, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Saliou P, Pers JO, Seror R, Saraux A.

Arthritis Care Res (Hoboken). 2017 Apr;69(4):528-535. doi: 10.1002/acr.22974.

26.

Painful and swollen hands 3 months after lungs graft: Suracute voriconazole-induced periostitis and exostosis.

Metayer B, Bode-Milin C, Ansquer C, Haloun A, Maugars Y, Berthelot JM.

Joint Bone Spine. 2017 Jan;84(1):97-98. doi: 10.1016/j.jbspin.2015.11.011. Epub 2016 Apr 23. No abstract available.

PMID:
27117297
27.

Detection of a lumbar foraminal venous varix by Color Doppler Ultrasound.

Darrieutort-Laffite C, Desal H, Berthelot JM, Le Goff B.

Joint Bone Spine. 2016 Jul;83(4):451-2. doi: 10.1016/j.jbspin.2015.09.009. Epub 2016 Apr 7.

PMID:
27068620
28.

Trafficking of antigens from gut to sacroiliac joints and spine in reactive arthritis and spondyloarthropathies: Mainly through lymphatics?

Berthelot JM, Claudepierre P.

Joint Bone Spine. 2016 Oct;83(5):485-90. doi: 10.1016/j.jbspin.2015.10.015. Epub 2016 Mar 8. Review.

PMID:
26968111
29.

Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study.

Devauchelle-Pensec V, Berthelot JM, Cornec D, Renaudineau Y, Marhadour T, Jousse-Joulin S, Querellou S, Garrigues F, De Bandt M, Gouillou M, Saraux A.

Ann Rheum Dis. 2016 Aug;75(8):1506-10. doi: 10.1136/annrheumdis-2015-208742. Epub 2016 Feb 29.

30.

Rampant infections of bone marrow stem cell niches as triggers for spondyloarthropathies and rheumatoid arthritis.

Berthelot JM, Sibilia J.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2):329-36. Epub 2016 Feb 9. Review.

PMID:
26886813
31.

B-cell and T-cell quantification in minor salivary glands in primary Sjögren's syndrome: development and validation of a pixel-based digital procedure.

Costa S, Schutz S, Cornec D, Uguen A, Quintin-Roué I, Lesourd A, Berthelot JM, Hachulla E, Hatron PY, Goeb V, Vittecoq O, Pers JO, Marcorelles P, Saraux A, Devauchelle-Pensec V.

Arthritis Res Ther. 2016 Jan 20;18:21. doi: 10.1186/s13075-016-0924-2.

32.

Blood and salivary-gland BAFF-driven B-cell hyperactivity is associated to rituximab inefficacy in primary Sjögren's syndrome.

Cornec D, Costa S, Devauchelle-Pensec V, Jousse-Joulin S, Marcorelles P, Berthelot JM, Chiche L, Hachulla E, Hatron PY, Goeb V, Vittecoq O, Saraux A, Pers JO.

J Autoimmun. 2016 Feb;67:102-110. doi: 10.1016/j.jaut.2015.11.002. Epub 2015 Dec 10.

PMID:
26688003
33.

Randomised study versus control group of customised therapeutic education for patients in follow-up for rheumatoid arthritis.

Pot-Vaucel M, Aubert MP, Guillot P, Glémarec J, Berthelot JM, Le Goff B, Maugars Y.

Joint Bone Spine. 2016 Mar;83(2):199-206. doi: 10.1016/j.jbspin.2015.05.017. Epub 2015 Dec 8.

PMID:
26677992
34.

Is electromagnetic hypersensitivity entirely ascribable to nocebo effects?

Berthelot JM.

Joint Bone Spine. 2016 Mar;83(2):121-3. doi: 10.1016/j.jbspin.2015.11.003. Epub 2015 Dec 8. No abstract available.

PMID:
26677989
35.

Sacroiliac joint edema by MRI: Far more often mechanical than inflammatory?

Berthelot JM, le Goff B, Maugars Y, Laredo JD.

Joint Bone Spine. 2016 Jan;83(1):3-5. doi: 10.1016/j.jbspin.2015.08.013. Epub 2015 Oct 19. No abstract available.

PMID:
26494590
36.

Strong opioids for noncancer pain due to musculoskeletal diseases: Not more effective than acetaminophen or NSAIDs.

Berthelot JM, Darrieutort-Lafitte C, Le Goff B, Maugars Y.

Joint Bone Spine. 2015 Dec;82(6):397-401. doi: 10.1016/j.jbspin.2015.08.003. Epub 2015 Oct 6. Review.

PMID:
26453108
37.

Sodium (18)F-sodium fluoride PET failed to predict responses to TNFα antagonist therapy in 31 patients with possible spondyloarthritis not meeting ASAS criteria.

Darrieutort-Laffite C, Ansquer C, Maugars Y, Le Goff B, Bodere F, Berthelot JM.

Joint Bone Spine. 2015 Dec;82(6):411-6. doi: 10.1016/j.jbspin.2015.08.012. Epub 2015 Oct 1.

PMID:
26431930
38.

Which and How Many Patients Should Be Included in Randomised Controlled Trials to Demonstrate the Efficacy of Biologics in Primary Sjögren's Syndrome?

Devauchelle-Pensec V, Gottenberg JE, Jousse-Joulin S, Berthelot JM, Perdriger A, Hachulla E, Hatron PY, Puechal X, Le Guern V, Sibilia J, Chiche L, Goeb V, Vittecoq O, Larroche C, Fauchais AL, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Dieudé P, Pers JO, Cornec D, Seror R, Mariette X, Nowak E, Saraux A.

PLoS One. 2015 Sep 14;10(9):e0133907. doi: 10.1371/journal.pone.0133907. eCollection 2015.

39.

Musculoskeletal symptoms in patients with cryopyrin-associated periodic syndromes: a large database study.

Houx L, Hachulla E, Kone-Paut I, Quartier P, Touitou I, Guennoc X, Grateau G, Hamidou M, Neven B, Berthelot JM, Lequerré T, Pillet P, Lemelle I, Fischbach M, Duquesne A, Le Blay P, Le Jeunne C, Stirnemann J, Bonnet C, Gaillard D, Alix L, Touraine R, Garcier F, Bedane C, Jurquet AL, Duffau P, Smail A, Frances C, Grall-Lerosey M, Cathebras P, Tran TA, Morell-Dubois S, Pagnier A, Richez C, Cuisset L, Devauchelle-Pensec V.

Arthritis Rheumatol. 2015 Nov;67(11):3027-36. doi: 10.1002/art.39292.

40.

Step-down strategy of spacing TNF-blocker injections for established rheumatoid arthritis in remission: results of the multicentre non-inferiority randomised open-label controlled trial (STRASS: Spacing of TNF-blocker injections in Rheumatoid ArthritiS Study).

Fautrel B, Pham T, Alfaiate T, Gandjbakhch F, Foltz V, Morel J, Dernis E, Gaudin P, Brocq O, Solau-Gervais E, Berthelot JM, Balblanc JC, Mariette X, Tubach F.

Ann Rheum Dis. 2016 Jan;75(1):59-67. doi: 10.1136/annrheumdis-2014-206696. Epub 2015 Jun 23.

PMID:
26103979
41.

Occurrence of a granulomatous mastitis and aseptic osteitis after anti-TNF therapy in a patient with pustular psoriasis.

Garraud T, Barbarot S, Berthelot JM, Le Goff B.

Joint Bone Spine. 2016 Jan;83(1):107-8. doi: 10.1016/j.jbspin.2015.04.007. Epub 2015 Jun 6. No abstract available.

PMID:
26054447
42.

Development of the Sjögren's Syndrome Responder Index, a data-driven composite endpoint for assessing treatment efficacy.

Cornec D, Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Seror R, Pers JO, Meiners PM, Vissink A, Bootsma H, Nowak E, Saraux A.

Rheumatology (Oxford). 2015 Sep;54(9):1699-708. doi: 10.1093/rheumatology/kev114. Epub 2015 May 8.

PMID:
25957440
43.

Reliability of histopathological salivary gland biopsy assessment in Sjögren's syndrome: a multicentre cohort study.

Costa S, Quintin-Roué I, Lesourd A, Jousse-Joulin S, Berthelot JM, Hachulla E, Hatron PY, Goeb V, Vittecoq O, Pers JO, Marcorelles P, Nowak E, Saraux A, Devauchelle-Pensec V.

Rheumatology (Oxford). 2015 Jun;54(6):1056-64. doi: 10.1093/rheumatology/keu453. Epub 2014 Nov 27.

PMID:
25433039
44.

RAPID3? Aptly named!

Berthelot JM.

Clin Exp Rheumatol. 2014 Sep-Oct;32(5 Suppl 85):S-80-4. Epub 2014 Oct 30. Review.

PMID:
25365094
45.

Essential role for CD103+ cells in the pathogenesis of spondyloarthritides.

Berthelot JM, Le Goff B, Martin J, Maugars Y, Josien R.

Joint Bone Spine. 2015 Jan;82(1):8-12. doi: 10.1016/j.jbspin.2014.07.011. Epub 2014 Sep 17. Review.

PMID:
25241337
46.

Long-term effectiveness and safety of interleukin-1 receptor antagonist (anakinra) in Schnitzler's syndrome: a French multicenter study.

Néel A, Henry B, Barbarot S, Masseau A, Perrin F, Bernier C, Kyndt X, Puechal X, Weiller PJ, Decaux O, Ninet J, Hot A, Aouba A, Astudillo L, Berthelot JM, Bonnet F, Brisseau JM, Cador B, Closs-Prophette F, Dejoie T, de Korwin JD, Dhote R, Fior R, Grosbois B, Hachulla E, Hatron PY, Jardel H, Launay D, Lorleac'h A, Pottier P, Moulis G, Serratrice J, Smail A, Hamidou M.

Autoimmun Rev. 2014 Oct;13(10):1035-41. doi: 10.1016/j.autrev.2014.08.031. Epub 2014 Aug 23.

47.

Alopecia areata occurring during anti-TNF therapy: a national multicenter prospective study.

Tauber M, Buche S, Reygagne P, Berthelot JM, Aubin F, Ghislain PD, Cohen JD, Coquerelle P, Goujon E, Jullien D, Brixi H, Jeudy G, Guennoc X, Martin A, Brénaut E, Hoppé E, Bertolotti A, Bardin T, Delaporte E, Allez M, Bachelez H, Seneschal J, Viguier M; Groupe de Recherche sur Psoriasis de Société Française de, Dermatologie; Club Rhumatismes et Inflammation (CRI); Groupe d'études thérapeutiques des affections inflammatoires du tube digestif (GETAID).

J Am Acad Dermatol. 2014 Jun;70(6):1146-9. doi: 10.1016/j.jaad.2014.03.005. No abstract available.

PMID:
24831323
48.

[Health and social information systems in support of local health planning: issues and challenges].

Bouchard L, Berthelot JM, Casteigts A, Chartier M, Trugeon A, Warnke J.

Glob Health Promot. 2014 Mar;21(1 Suppl):15-22. doi: 10.1177/1757975913512162. French.

PMID:
24737809
49.

Treatment of primary Sjögren syndrome with rituximab: a randomized trial.

Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puéchal X, Le Guern V, Sibilia J, Gottenberg JE, Chiche L, Hachulla E, Hatron PY, Goeb V, Hayem G, Morel J, Zarnitsky C, Dubost JJ, Pers JO, Nowak E, Saraux A.

Ann Intern Med. 2014 Feb 18;160(4):233-42.

PMID:
24727841
50.

Is a patient questionnaire without a joint examination as undesirable as a joint examination without a patient questionnaire?

Pincus T, Gibson KA, Berthelot JM.

J Rheumatol. 2014 Apr;41(4):619-21. doi: 10.3899/jrheum.140074. No abstract available.

PMID:
24692600

Supplemental Content

Loading ...
Support Center